Pacific Biosciences of California, Inc.
PACB· Nasdaq
Released Nov 14, 2011, after the close
10-Q filed Nov 14, 2011, 45 days after period end · 0001193125-11-310296
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Revenue | $10.52M | $220.00K |
| Net Income | -$29.28M | -$40.71M |
| EPS Diluted | -$0.54 | -$39.70 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 14, 2011 · 45 d after period end
19.6% from the close of Nov 9, 2011 to the close of Nov 18, 2011, the first after the release.